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Abstract
OBJECTIVES: The aim of this study was to investigate whether total arch replacement (TAR) during initial surgery for root aneurysm
should be routinely performed in patients with Marfan syndrome (MFS).
METHODS: Retrospective analysis of 94 consecutive MFS patients fulﬁlling Ghent criteria who underwent 148 aortic surgeries and were
followed at this institution during the past 16 years.
RESULTS: The mean follow-up interval was 8.8 ± 7 years. Initial presentation was acute aortic dissection (AAD) in 35% of patients (76%
Type A and 24% Type B) and aneurismal disease in 65%. TAR was performed in 8% of patients during initial surgery for AAD (otherwise
a hemi-arch replacement was performed) and 1.6% in elective root repair. Secondary TAR had to be performed in only 3% of patients
without, but in 33% following AAD (33% Type A and 33% Type B; P = 0.0001). Thirty-day, 6-month, 1-year and overall mortalities were
3.2, 5.3, 6.4 and 11.7%, respectively. Operative and 30-day mortalities in secondary aortic arch replacement were zero. Secondary TAR
after AAD did not increase the need for the replacement of the entire thoracoabdominal aorta during follow-up compared with
patients without secondary TAR (37 vs 40%, P = 1.0).
CONCLUSIONS: MFS patients undergoing elective root repair have small risk of reinterventions on the aortic arch, and primary prophy-
lactic replacement does not seem to be justiﬁed. In patients with AAD, the need for reinterventions is precipitated by the dissection
itself and not by limiting the procedure to the hemi-arch replacement in the emergency setting. Limiting surgery to the aortic root,
ascending aorta and proximal aortic arch is associated with low mortality in MFS patients presenting with AAD.
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INTRODUCTION
Aneurysm of the aortic root is the hallmark feature of Marfan
syndrome (MFS), an autosomal dominant disorder imposed by
mutations in the gene encoding for the extracellular matrix
protein ﬁbrillin-1 [1, 2]. Although patients with MFS exhibit
skeletal, ocular and cardiovascular manifestation, aortic aneur-
ysm determines morbidity and mortality in this patient
population [3].
Aortic aneurysm in MFS is typically pear-shaped and involves
progressive dilatation of the sinus of Valsalva. In most of the
MFS patients presenting with aortic root aneurysm on a
non-emergent basis, the aneurysm is limited to the root and
proximal ascending aorta and shows almost normal diameter at
the level of the brachiocephalic trunk.
In MFS patients presenting with acute aortic dissection (AAD)
Stanford Type A, the dissection frequently progresses beyond
the ascending aorta through the arch into the descending and
abdominal aorta as seen in non-MFS patients. The low morbidity
and mortality rates in MFS patients undergoing elective root
surgery have fostered the concept of prophylactic aortic surgery
to prevent AAD and its sequelae [4]. Life expectancy in MFS
patients has dramatically improved over the past decades
through the prevention of AAD [5].
As several recent studies suggested a shift of morbidity and
mortality towards the distal aorta [6–8], the question remains to
what extent the aorta should be replaced during initial surgery
for either elective root repair or emergency surgery for Type A
dissection.
In the acute setting, the surgeon has to weigh the increased
operative risk associated with a total arch replacement (TAR)
against the risk of future reintervention and interstage mortality.
Unfortunately, there are little data available to estimate the true
additional burden in terms of myocardial injury or neurological
complications regarding primary TAR in elective patients or
those presenting with Type A dissection.
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Aim
The aim of this study was to investigate whether TAR during
initial surgery for root aneurysm should be routinely performed
in patients with MFS. Since it can be assumed that additional
primary TAR carries a certain extra risk for the patient, we also
compared outcomes in patients with and without secondary TAR
in order to analyse whether primary TAR prevents further inter-
ventions aside from arch replacement.
PATIENTS AND METHODS
Data from 94 MFS patients (mean age at initial surgery 43 ± 16
years, range 8–69 years, 55% male patients) fulﬁlling Ghent criteria
who underwent 148 major aortic operations and were followed at
this institution since 1995 were retrospectively analysed. Patients
are followed-up in our MFS clinics 3, 6 and 12 months after
surgery and then depending on the ﬁndings, at least once per
year. Patients were evaluated using electrocardiography-gated,
computed tomography (CT) angiography to plan surgery, as a
follow-up in patients with dissections and in patients undergoing
surgery on an emergent basis. In benign cases or after uneventful
elective surgery, magnetic resonance imaging was performed to
reduce cumulative radiation exposure.
Furthermore, a phone interview was conducted according to a
standardized questionnaire that was sent to the patients in
advance. Individual informed consent was obtained, and patients
were asked if we were allowed to contact their primary care pro-
vider regarding recent developments, changes in medication or
CT scans that were performed outside our institution. Thus, a
99% completeness of follow-up was achieved.
This study was approved by the institutional review board and
individual informed consent from the patient or, in the case of
minors, the parent or the legal guardian was obtained.
Statistical analysis
The values are given in mean ± standard deviation, when appro-
priate. In addition to descriptive statistics, data underwent a
Kaplan–Meier survival analysis, with either reoperation or death
as an event, followed by a log-rank test to compare the event
risk for patients with or without history of aortic dissection or
with or without secondary TAR. Analysis was performed with
SPSS version 15.0 software (SPSS, Inc., Chicago, IL, USA).
Indication for surgery and surgical techniques
Indications for surgery generally followed the 2010 AHA guide-
lines [9] for the treatment of thoracic aortic disease. Since 15% of
patients with MFS dissect at a diameter of <50 mm, aortic root
surgery was considered at a diameter of 45–50 mm or progres-
sive dilatation of >5 mm per year [5, 6, 10]. If aortic regurgitation
was present and aortic root size was <45 mm, indication for
surgery depended on the extent of regurgitation and hence
left ventricular dimensions. Prophylactic root replacement was
suggested in women wishing to conceive if aortic root size
exceeded 40 mm. Aortic root replacement by means of a modi-
ﬁed Bentall procedure or valve-sparing root replacement (VSRR)
in suitable candidates was the treatment of choice [11, 12] in the
present study. If the aorta at the level of the brachiocephalic
trunk was 35 mm or larger, repair was extended into the arch by
performing a hemi-arch replacement.
Surgical repair of the aortic arch and descending aorta was
considered if the diameter exceeded 55–60 mm or in the case
of rapid enlargement, e.g. after Stanford Type B dissection. In
patients presenting with acute Stanford Type A dissection, the
distal anastomosis was performed by removing the concavity of
the aortic arch using moderate hypothermic circulatory arrest
with bilateral antegrade cerebral perfusion [13]. If TAR was ne-
cessary, separate reimplantation of the supra-aortic branches
using a vascular graft with multiple side branches was preferred.
While the hemi-arch replacement was considered standard of
care in patients presenting with Type A dissection, primary TAR
was only done if needed in order to perform a sufﬁciently stable
distal anastomosis or to prevent neurological damage by ob-
struction of the supra-aortic branches. For the purpose of this
study, TAR was deﬁned as a circular anastomosis between the
brachiocephalic trunk and the left subclavian artery with reim-
plantation of at least one supra-aortic branch.
Management of cardiopulmonary bypass
The management of cardiopulmonary bypass and circulatory
arrest has improved over the course of the study [13, 14]. Most
notably, the routine use of bilateral selective antegrade cerebral
perfusion began in 2004. In elective cases scheduled for aortic
root replacement, standard aortic and right atrial cannulation
were performed, and cardiopulmonary bypass was conducted in
moderate hypothermia (32°C). Patients with acute Stanford Type
A aortic dissection were cannulated through the right axillary
artery whenever possible and cooled to 20°C tympanic and 26°
C core temperature. Patients with chronic ascending aortic
aneurysms involving the proximal aortic arch are cooled to 26°C
tympanic and 30°C core temperature. Bilateral selective ante-
grade cerebral perfusion was either performed through perfu-
sion catheters in both common carotid arteries or via the right
axillary arterial cannula (using the arterial return line) and an
additional perfusion catheter in the left common carotid artery
with perfusion pressure not exceeding 50–60 mmHg. Cerebral per-
fusion was monitored using continuous bilateral near-infrared ox-
imetry. Algorithmic analysis of electroencephalogram data allowed
the conﬁrmation of burst suppression before the administration of
sodium thiopenthal and the initiation of circulatory arrest.
RESULTS
Primary interventions on the aortic root
Initial presentation was AAD in 35% of patients and aneurismal
disease in 65%. In patients undergoing elective repair of the root
and ascending aorta, 46% received a modiﬁed Bentall procedure,
44% a VSRR, in 3% only the ascending aorta was replaced and
5% primarily received other procedures (heart transplantation,
the use of homograft for aortic root replacement, etc.). In the
group of patients presenting with AAD, 76% presented with
Stanford Type A and 24% with Stanford Type B dissection. In
patients with Type A dissection, a modiﬁed Bentall procedure
was performed in 68%, and in 32% of patients only the ascend-
ing aorta was replaced since the diagnosis of MFS was not
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established at the time of surgery (mainly in the early years of
the observation period). In the group of patients primarily pre-
senting with Type B dissection, 25% suffered from Type A dissec-
tion during follow-up and underwent a modiﬁed Bentall
procedure.
Primary aortic arch interventions
Primary TAR was only performed in 1.6% of patients undergoing
elective aortic root repair. Simultaneous TAR was performed in
8% of patients with Type A dissection and 7% if including those
patients who initially presented with Type B dissection that later
evolved into Type A dissection.
Secondary aortic arch interventions
Mean time from initial surgery to secondary TAR was 8 ± 6 years.
Secondary TAR after primary elective proximal repair had to be
performed in only 2 (3%) patients. One patient needed TAR 6
years after a Bentall procedure and 1, 3 years after replacement
of the ascending aorta followed by Type B dissection, replace-
ment of the descending aorta and ﬁnally replacement of the
aortic root by a modiﬁed Bentall procedure.
In patients after successful repair of Type A dissection, second-
ary TAR became necessary in 33% of patients (P = 0.0001). There
was no signiﬁcant difference in secondary TAR regarding the
type of proximal procedure at initial surgery. Reintervention
became necessary in 38% of patients after replacement of the
ascending aorta and in 35% after a Bentall procedure. In those 2
patients with Type A dissection after initial presentation with
Type B dissection, 1 needed secondary TAR. Interestingly, sec-
ondary TAR had to be performed in only 27% of cases at the
time of the ﬁrst reintervention (Fig. 1).
Implantation of an elephant trunk to prepare for later surgery
on the descending aorta was performed in 27% of patients
during secondary TAR, including 1 patient who presented with
Type B dissection and a dilated descending aorta, but had to
undergo proximal repair ﬁrst due to a very large root aneurysm.
Reoperations in patients after secondary
total arch replacement
Patients initially presenting with AAD who underwent secondary
TAR during follow-up had a higher rate and number of reopera-
tions compared with the group that never had the aortic arch
replaced (78 vs 43%, P = 0.12; 1.5 vs 3.4 surgeries per patient).
Complete thoracoabdominal aortic replacement (TAAR) in
patients initially presenting with AAD became necessary in 44%
of patients with secondary TAR and in 24% (P = 0.21) of those
without secondary TAR. Interestingly, if including those patients
who suffered from AAD at any point during follow-up, the rate
of TAAR in patients with secondary TAR was 40% compared with
37% (P = 1.0) in patients without aortic arch replacement.
Circulatory arrest in total arch replacement
and neurological complications
Selective antegrade cerebral perfusion was performed in all
patients since 2004. The duration of circulatory arrest was
17 ± 11 min during initial surgery for proximal repair, including
those cases with primary TAR. In patients with secondary TAR,
circulatory arrest time was 25 ± 11 min.
Cerebrovascular complications occurred in 6 patients (4% of
performed surgeries) of the overall study population, all of them
except 1 in those with a history of AAD. In 3 patients, symptoms
completely resolved during follow-up, including 1 patient after
secondary TAR 16 years after a Bentall procedure. Two patients
showed residual hemiparesis, including 1 with already pre-
existing neurological impairment after a modiﬁed Bentall pro-
cedure and primary TAR due to Type A dissection. The patient
was referred from an outside hospital for progressive dilatation
of the residual aortic tissue surrounding the supra-aortic
branches. The patient underwent redo arch surgery without new
neurological events. One patient died after suffering from stroke
during elective coronary angiography 6 months after surgery for
Type A dissection.
Therefore, there was no patient who suffered from persistent
neurological impairment after primary or secondary TAR in our
institution.
Follow-up and mortality
The mean follow-up was 8.8 ± 7 years. Thirty-day, 6-month,
1-year and overall mortalities were 3.2, 5.3, 6.4 and 11.7%, re-
spectively. Operative mortality in patients presenting with acute
Type A dissection was zero. Thirty-day mortality was 7%, with
1 patient suffering from rupture of the descending aorta 6 days
after initial surgery for Type A dissection and 1 patient experien-
cing major perioperative stroke. Operative and 30-day mortal-
ities in secondary TAR were zero.
Freedom from reoperation and survival
There were no signiﬁcant differences in survival between
patients who underwent primary, secondary or no TAR. Survivals
at 5, 10, 15 and 20 years were 91, 91, 87 and 77% in patients
without TAR, 100% in patients with primary TAR at 5 and 10
Figure 1: Graph depicting the number of total arch replacements compared
with all reinterventions performed.
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years and 100, 100, 80 and 80% in patients with secondary TAR,
respectively (Fig. 2).
Freedom from secondary arch replacement in patients initially
presenting with AAD was signiﬁcantly worse compared with
patients without AAD (log rank P = 0.002). Freedom from second-
ary TAR at 5, 10, 15 and 20 years were 96, 96, 96 and 72% in
patients without initial dissection and 80, 67, 53 and 42% at 5, 10,
15 and 20 years in patients initially presenting with AAD (Fig. 3).
Freedom from reoperation at 5, 10 and 15 years in patients
presenting initially with AAD and needing secondary TAR during
follow-up were 51, 30 and 8% compared with 77, 65 and 29% in
patients without secondary TAR during follow-up. Freedom from
reoperation at 5, 10 and 15 years in patients initially presenting
without AAD and needing secondary TAR during follow-up were
67, 44 and 44% compared with 88, 61 and 32% in patients
without secondary TAR during follow-up (Fig. 4).
DISCUSSION
The additional burden of replacing the aortic arch as an adjunct
to elective or emergent proximal repair is not very well deﬁned
and makes comparisons with patients undergoing secondary
TAR difﬁcult. Most of the papers reporting on outcomes after
surgery for Type A dissection or those dealing with reinterven-
tion after proximal repair do not discuss arch-related morbidity
and mortality separately [15–17]. Although most of the authors
report their general experience, it can be assumed that most
larger series contain a signiﬁcant number of MFS that may inﬂu-
ence the results, but again, this is not reﬂected in the discussion.
On the other hand, even in larger series reporting results from
patients with MFS, the number of those undergoing aortic arch
surgery is small, and reports on mortality or neurological
outcome are mostly anecdotal [18].
Although, in our series, there was no persistent neurological
impairment after either primary or secondary TAR, the low rate
of primary TARs performed makes a valid comparison difﬁcult.
The same applies for mortality since survival in both primary
and secondary TAR was 100% at 10 years. One could argue that
the number of patients in need of secondary TAR may have died
during follow-up, but that is not the case since there was no sig-
niﬁcant difference in mortality compared with those patients
who never had the arch replaced.
The major risk factor for the need of reintervention on the
aortic arch and distal aorta after repaired Type A dissection is a
patent false lumen [17]. Therefore, several groups recently began
to advocate TAR and implantation of a frozen elephant trunk
(FET) in addition to proximal repair in Type A dissection. Sun et al.
[19] recently published their experiences with 44 MFS patients in-
cluding 57% of patients with chronic Type A dissection in which
they performed primary TAR with implantation of FET. They
reported 4.8% mortality over a mean follow-up of 3 years, only 1
stroke and no other neurological event. In contrast to other major
surgical series involving MFS patients, the rate of reinterventions
Figure 2: Kaplan–Meier curve showing no signiﬁcant differences regarding
survival in patients who underwent primary, secondary or no TARs.
Figure 3: Kaplan–Meier curve showing signiﬁcantly worse freedom from sec-
ondary TARs in patients initially presenting with AAD compared with those
without AAD.
Figure 4: Kaplan–Meier curve depicting freedom from reoperation in patients
initially presenting with or without AAD as well as those with or without sec-
ondary TARs.
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was surprisingly low. Although primary technical success seems
feasible, there is evidence that continued dilatation of the aorta
around the stent graft will limit the durability of the repair [20].
We only use TEVAR in very selected cases in MFS to bridge a
short aneurismal segment between two polyester grafts.
Interestingly, groups based on Asia tend to advocate a more
aggressive approach and mostly recommend TAR during initial
surgery for Type A dissection. It has been discussed whether this
is also due to a more favourable anatomy in the Asian popula-
tion and a more pronounced atherosclerotic burden in Western
countries, which increases the risk for stroke during TAR.
In 2009, Uchida et al. [21] published one of the very few
reports comparing the hemi-arch replacement with an open
distal anastomosis to TAR with implantation of an FET. In 120
patients presenting with acute Type A dissection, mortality was
only 4% with no new cerebral events and a survival of 95% at 5
years in the FET and 69% in the hemi-arch group.
Although pseudoaneurysm or dehiscence at the level of the
distal anastomosis has been described as a frequent cause for
reoperation [16], it was a rare event in our series. Obviously, MFS
patients do have a more fragile tissue, and our strategy to use
glue and bovine pericardium to reinforce all anastomosis, in-
cluding those of the coronary buttons, may have positively inﬂu-
enced the outcome in this series.
Although the need for replacing the entire thoracoabdominal
aorta was somewhat higher in the group with secondary TAR,
this did not reach statistical signiﬁcance and the difference com-
pletely vanishes when including those patients who suffered
from acute dissection at any point during follow-up.
These data suggest that it is the dissection itself that drives the
need for reoperations in these patients and that the aortic arch is
only one of the many segments that has to be repaired over the
years. In a large series of MFS patients, Tagusari et al. [18] showed
that there was no signiﬁcant difference regarding the rate of reo-
peration in patients with persisting dissection in the descending
aorta after TAR compared with those without. The rate for reinter-
ventions was 50% in both groups at 10 years. Nevertheless, the
rate of reoperation was higher in patients with a dissection in the
aortic arch where only the ascending aorta was replaced com-
pared with those patients without a dissected arch. Therefore, in
the rare cases, where the dissection is conﬁned to the aortic arch,
complete exclusion of the dissection may reduce the need for
reinterventions and should be attempted.
In large series of 95 patients with MFS, 9.7% required reinter-
ventions on the distal aorta after elective aortic root surgery,
compared with 44% after surgery for acute Type A dissection, in-
cluding 4 (15%) with secondary TAR [15]. Although the rate of
secondary TAR in our population was higher, comparisons are
difﬁcult since the paper does not specify the percentage of
primary TAR during the initial proximal repair.
Bachet et al. [22] reported that, in their experience with MFS
patients, secondary TAR had to be performed in 16% after elective
root surgery and in 73% of patients after Type A dissection com-
pared with 3 and 33% of patients, respectively, in the current
series. In-hospital mortality was 13 with 9.2% major neurological
events. In the subgroup of patients with secondary TAR, mortality
was considerably higher than in our series with 9 and 22% of
patients suffering from neurological events, although there was no
mortality and no neurological event after the initial surgery.
In our current series, the need for secondary TAR in patients
after elective proximal repair was very low such that primary
TAR cannot be recommended. Nevertheless, we advocate liberal
use of a short circulatory arrest to perform the hemi-arch re-
placement if there is evidence of dilatation at the level of the
brachiocephalic trunk.
Replacing the aortic arch during initial surgery for AAD obvi-
ously spares the patients secondary TAR, but it does not protect
the patient from reoperations on primarily non-treated aortic
segments, ultimately leading up to replacement of the entire
aorta. Furthermore, two-thirds of patients after AAD will never
need additional arch procedures if the proximal arch was
addressed during the initial surgery.
Considering the advances in aortic surgery over the past
decade, even complex reoperations seem to carry a moderate
risk if performed in an elective setting. Therefore, we suggest
delaying major additional procedures during initial surgery for
AAD since they can be performed more safely under elective
circumstances. In our current study, there was no ‘interstage’
mortality, new neurological events or operative or 30-day mor-
tality after secondary TAR.
Therefore, we suggest that, within the spectrum of repairing
acute Type A dissection ranging from isolated replacement of
the ascending aorta to root replacement with TAR and implant-
ation of a FET, our strategy to perform aggressive root replace-
ment and a hemi-arch procedure with replacement of the
concavity of the aortic arch seems to balance the need for
further reinterventions and the operative risk.
CONCLUSION
MFS patients undergoing elective root repair have small risk of
reinterventions on the aortic arch, and primary replacement
does not seem to be justiﬁed.
In patients with AAD, the need for reinterventions is precipi-
tated by the dissection itself and not by limiting the procedure
to the hemi-arch replacement in the emergency setting. This
strategy is associated with low mortality in MFS patients present-
ing with AAD.
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APPENDIX. CONFERENCE DISCUSSION
Dr T. Dessing (Nieuwegein, Netherlands): I think in Antonius Hospital in
Nieuwegein we have the same strategy and same approach for these kinds of
patients. I have one question for you. What is your opinion on replacement
of the total arch with a frozen elephant trunk in Marfan patients with a type
A dissection?
Dr Schoenhoff: We were very hesitant to perform any type of endovascular
procedure in this patient population. In a report by Norwood and colleagues
it was shown that the aorta dilates around the stented segment. So we only
use stent grafting to bridge a short aneurysmal segment between two already
replaced aortic segments so that we can use the Dacron as a landing zone,
but we won’t do a frozen elephant trunk in a Marfan patient.
Dr W. Harringer (Braunschweig, Germany): May I just have a brief last
question. In my experience, the worst type of Marfan patients are the Marfan
type II, the Loeys-Dietz syndrome patients, which is rather difﬁcult, of course,
to assess preoperatively. But this might be the only group where maybe a
more aggressive strategy could be recommended because of the huge pro-
gression of the disease and the malignant course. What are your thoughts on
that? Are you meanwhile doing routine testing for this type of Marfan?
Dr Schoenhoff: In our Marfan population, 80% of patients underwent
genetic testing and 80% of these were mutation positive. And actually, in
retrospect, we also had some Loeys-Dietz patients that were primarily treated
as having Marfan syndrome. Interestingly, many of the recent publications
just report on children or young adolescents with very aggressive forms of
this disease, but we forget that we all already carried out surgery on these
patients in past. I think that what has been published now is just the tip of
the iceberg, and I’m not sure if the majority of Loeys-Dietz patients are very
much different from Marfan patients with regard to the aortic arch.
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In their article titled ‘Should aortic arch replacement be
performed during initial surgery for aortic root aneurysm in
patients with Marfan syndrome?’ Schoenhoff et al. raise again a
very important question which, after several decades of aortic
surgery in this particular group of patients, still remains
unresolved.
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